found that in ovarian cancer, ERBB2 up-regulates ZEB1 in non-attached cells, FOX1 up-regulates ZEB1, and ZEB1 inhibits FOXM1 expression through a negative feedback mechanism. Here, ERBB2 is linked to ovarian carcinoma.